Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis
Objective: Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA) and it has been studied in RA resistance recently. P-glycoprotein (P-gp) is one of the important transporters that mediate MTX resistance. This study investigated the effect of Paeoniflorin-6′-O-benz...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219334845 |
id |
doaj-3148c7ad09494d86ae87464795f43e99 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hao Tang Yi-jin Wu Feng Xiao Bin Wang James Asenso Yong Wang Wei Sun Chun Wang Wei Wei |
spellingShingle |
Hao Tang Yi-jin Wu Feng Xiao Bin Wang James Asenso Yong Wang Wei Sun Chun Wang Wei Wei Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis Biomedicine & Pharmacotherapy Methotrexate P-glycoprotein Paeoniflorin-6′-O-benzene sulfonate Adjuvant arthritis Resistance |
author_facet |
Hao Tang Yi-jin Wu Feng Xiao Bin Wang James Asenso Yong Wang Wei Sun Chun Wang Wei Wei |
author_sort |
Hao Tang |
title |
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis |
title_short |
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis |
title_full |
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis |
title_fullStr |
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis |
title_full_unstemmed |
Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis |
title_sort |
regulation of cp-25 on p-glycoprotein in synoviocytes of rats with adjuvant arthritis |
publisher |
Elsevier |
series |
Biomedicine & Pharmacotherapy |
issn |
0753-3322 |
publishDate |
2019-11-01 |
description |
Objective: Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA) and it has been studied in RA resistance recently. P-glycoprotein (P-gp) is one of the important transporters that mediate MTX resistance. This study investigated the effect of Paeoniflorin-6′-O-benzene sulfonate (code: CP-25) in the resistance of P-gp-mediated MTX to RA. Methods: Adjuvant arthritis (AA) was induced in rats via complete Freund’s adjuvant. The experimental groups were divided into normal group; AA model group; monotherapy groups, including CP-25, MTX and dexamethasone; and CP-25 combined with MTX group. The expression of P-gp in synovial tissue was measured by western blot and histochemistry. Besides, P-gp high expression of human hepatoma cell line Bel7402/5-FU and Bel7402 were chose to study in MTX resistance and the function of P-gp was detected by Flow cytometry. Results: CP-25 had a good therapeutic effect on AA rats, significantly improved manifestations and reduced the expression of P-gp in synovial tissue, spleen medulla and small intestinal epithelial cells in the apical tissues of AA rats. In addition, CP-25 significantly inhibited the up-regulation of P-gp induced by TNF-α stimulation in synoviocytes. Furthermore, according to the accumulation and efflux of rhodamine 123 in Bel7402/5-FU resistant cells and Bel7402 sensitive cells, CP-25 could reverse the resistance of MTX in Bel7402/5-FU cells compared with Bel7402 cells, which was reflected by the reduced IC50 values of MTX. Further study indicated that CP-25 could decrease P-gp expression and inhibit P-gp function in Bel7402/5-FU cells. Conclusion: CP-25 regulates the expression of P-gp and inhibits the function of P-gp, thereby improving the resistance of MTX. |
topic |
Methotrexate P-glycoprotein Paeoniflorin-6′-O-benzene sulfonate Adjuvant arthritis Resistance |
url |
http://www.sciencedirect.com/science/article/pii/S0753332219334845 |
work_keys_str_mv |
AT haotang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT yijinwu regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT fengxiao regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT binwang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT jamesasenso regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT yongwang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT weisun regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT chunwang regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis AT weiwei regulationofcp25onpglycoproteininsynoviocytesofratswithadjuvantarthritis |
_version_ |
1721435195715878912 |
spelling |
doaj-3148c7ad09494d86ae87464795f43e992021-05-20T07:39:02ZengElsevierBiomedicine & Pharmacotherapy0753-33222019-11-01119Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritisHao Tang0Yi-jin Wu1Feng Xiao2Bin Wang3James Asenso4Yong Wang5Wei Sun6Chun Wang7Wei Wei8Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, ChinaInstitute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China; Corresponding authors at: Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China.Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei, 230032, China; Anhui Collaborative Innovation Centre of Anti-Inflammatory and Immune Medicine, Hefei, 230032, China; Corresponding authors at: Institute of Clinical Pharmacology, Anhui Medical University, Hefei, 230032, China.Objective: Methotrexate (MTX) is a commonly used drug for the treatment of rheumatoid arthritis (RA) and it has been studied in RA resistance recently. P-glycoprotein (P-gp) is one of the important transporters that mediate MTX resistance. This study investigated the effect of Paeoniflorin-6′-O-benzene sulfonate (code: CP-25) in the resistance of P-gp-mediated MTX to RA. Methods: Adjuvant arthritis (AA) was induced in rats via complete Freund’s adjuvant. The experimental groups were divided into normal group; AA model group; monotherapy groups, including CP-25, MTX and dexamethasone; and CP-25 combined with MTX group. The expression of P-gp in synovial tissue was measured by western blot and histochemistry. Besides, P-gp high expression of human hepatoma cell line Bel7402/5-FU and Bel7402 were chose to study in MTX resistance and the function of P-gp was detected by Flow cytometry. Results: CP-25 had a good therapeutic effect on AA rats, significantly improved manifestations and reduced the expression of P-gp in synovial tissue, spleen medulla and small intestinal epithelial cells in the apical tissues of AA rats. In addition, CP-25 significantly inhibited the up-regulation of P-gp induced by TNF-α stimulation in synoviocytes. Furthermore, according to the accumulation and efflux of rhodamine 123 in Bel7402/5-FU resistant cells and Bel7402 sensitive cells, CP-25 could reverse the resistance of MTX in Bel7402/5-FU cells compared with Bel7402 cells, which was reflected by the reduced IC50 values of MTX. Further study indicated that CP-25 could decrease P-gp expression and inhibit P-gp function in Bel7402/5-FU cells. Conclusion: CP-25 regulates the expression of P-gp and inhibits the function of P-gp, thereby improving the resistance of MTX.http://www.sciencedirect.com/science/article/pii/S0753332219334845MethotrexateP-glycoproteinPaeoniflorin-6′-O-benzene sulfonateAdjuvant arthritisResistance |